HDAC6 and HIV-associated neurocognitive disorder: Importantly, the neurotoxic effect of gp120 is reversed by both tubacin and ACY-1215, suggesting that HDAC6 inhibition may be a viable therapeutic strategy to reduce synaptopathy and neuronal damage seen in HAND subjects.